Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma

R. Ottanelli, E. Rosi, I. Romagnoli, M. C. Ronchi, B. Lanini, M. Grazzini, M. Filippelli, L. Stendardi, R. Duranti, Giorgio Scano

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The inter-relationship between the perception of bronchoconstriction, bronchial hyper-responsiveness and temporal adaptation in asthma is still a matter of debate. In a total of 52 stable asthmatic patients, 32 without airway obstruction [forced expiratory volume in 1 s (FEV 1)/vital capacity (VC) 84.1% (S.D. 7.9%)], and 20 with airway obstruction [FEV 1/VC 60% (4%)], we assessed the perception of bronchoconstriction during methacholine inhalation by using: (i) the slope and intercept of the Borg and VAS (Visual Analog Scale) scores against the decrease in FEV 1, expressed as a percentage of the predicted value; and (ii) the Borg and VAS scores at a 20% decrease in FEV 1 from the lowest post-saline level (PB 20). Bronchial hyper-responsiveness was assessed as the provocative concentration of methacholine causing a 20% fall in FEV 1 (PC 20FEV 1). The reduction in FEV 1 was significantly related to the Borg and VAS scores, with values for the group mean slope and intercept of this relationship of 0.13 (S.D. 0.08) and -1.1 (3.02) for Borg, and 1.5 (1.19) and -12.01 (35) for VAS. PB 20 was 3 (1.75) with Borg scores and 34.6 (20.5) with VAS scores. Compared with the subgroup without airway obstruction, the obstructed subgroup exhibited similar slopes, but lower Borg and VAS intercepts. For similar decreases in FEV 1 (5-20% decreases from the lowest post-saline values), the Borg and VAS scores were lower in the non-obstructed than in the obstructed subgroup. PC 20FEV 1 was significantly related to both Borg PB 20 and VAS PB 20 when considering all patients. When assessing the subgroups, PC 20FEV 1 was related to Borg PB 20 and VAS PB 20 in the non-obstructed subjects, but not in the obstructed subjects. In neither subgroup was the log of the cumulative dose related to the Borg and VAS scores at the end of the test. We conclude that, unlike in previous studies, the ability to perceive acute bronchoconstriction may be reduced as background airflow obstruction increases in asthma. Bronchial hyper-responsiveness did not play a major role in perceived breathlessness in patients without airway obstruction, and even less of a role in patients with obstruction. The cumulative dose of agonist did not appear to influence the perception of bronchoconstriction.

Original languageEnglish
Pages (from-to)681-687
Number of pages7
JournalClinical Science
Volume98
Issue number6
Publication statusPublished - 2000

Fingerprint

Bronchoconstriction
Visual Analog Scale
Asthma
Forced Expiratory Volume
Airway Obstruction
Methacholine Chloride
Vital Capacity
Aptitude
Dyspnea
Inhalation

Keywords

  • Bronchial asthma
  • Dyspnoea
  • Hyper-responsiveness

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ottanelli, R., Rosi, E., Romagnoli, I., Ronchi, M. C., Lanini, B., Grazzini, M., ... Scano, G. (2000). Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. Clinical Science, 98(6), 681-687.

Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. / Ottanelli, R.; Rosi, E.; Romagnoli, I.; Ronchi, M. C.; Lanini, B.; Grazzini, M.; Filippelli, M.; Stendardi, L.; Duranti, R.; Scano, Giorgio.

In: Clinical Science, Vol. 98, No. 6, 2000, p. 681-687.

Research output: Contribution to journalArticle

Ottanelli, R, Rosi, E, Romagnoli, I, Ronchi, MC, Lanini, B, Grazzini, M, Filippelli, M, Stendardi, L, Duranti, R & Scano, G 2000, 'Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma', Clinical Science, vol. 98, no. 6, pp. 681-687.
Ottanelli R, Rosi E, Romagnoli I, Ronchi MC, Lanini B, Grazzini M et al. Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. Clinical Science. 2000;98(6):681-687.
Ottanelli, R. ; Rosi, E. ; Romagnoli, I. ; Ronchi, M. C. ; Lanini, B. ; Grazzini, M. ; Filippelli, M. ; Stendardi, L. ; Duranti, R. ; Scano, Giorgio. / Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. In: Clinical Science. 2000 ; Vol. 98, No. 6. pp. 681-687.
@article{a4902b7da42d44029f2613cfd62858fd,
title = "Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma",
abstract = "The inter-relationship between the perception of bronchoconstriction, bronchial hyper-responsiveness and temporal adaptation in asthma is still a matter of debate. In a total of 52 stable asthmatic patients, 32 without airway obstruction [forced expiratory volume in 1 s (FEV 1)/vital capacity (VC) 84.1{\%} (S.D. 7.9{\%})], and 20 with airway obstruction [FEV 1/VC 60{\%} (4{\%})], we assessed the perception of bronchoconstriction during methacholine inhalation by using: (i) the slope and intercept of the Borg and VAS (Visual Analog Scale) scores against the decrease in FEV 1, expressed as a percentage of the predicted value; and (ii) the Borg and VAS scores at a 20{\%} decrease in FEV 1 from the lowest post-saline level (PB 20). Bronchial hyper-responsiveness was assessed as the provocative concentration of methacholine causing a 20{\%} fall in FEV 1 (PC 20FEV 1). The reduction in FEV 1 was significantly related to the Borg and VAS scores, with values for the group mean slope and intercept of this relationship of 0.13 (S.D. 0.08) and -1.1 (3.02) for Borg, and 1.5 (1.19) and -12.01 (35) for VAS. PB 20 was 3 (1.75) with Borg scores and 34.6 (20.5) with VAS scores. Compared with the subgroup without airway obstruction, the obstructed subgroup exhibited similar slopes, but lower Borg and VAS intercepts. For similar decreases in FEV 1 (5-20{\%} decreases from the lowest post-saline values), the Borg and VAS scores were lower in the non-obstructed than in the obstructed subgroup. PC 20FEV 1 was significantly related to both Borg PB 20 and VAS PB 20 when considering all patients. When assessing the subgroups, PC 20FEV 1 was related to Borg PB 20 and VAS PB 20 in the non-obstructed subjects, but not in the obstructed subjects. In neither subgroup was the log of the cumulative dose related to the Borg and VAS scores at the end of the test. We conclude that, unlike in previous studies, the ability to perceive acute bronchoconstriction may be reduced as background airflow obstruction increases in asthma. Bronchial hyper-responsiveness did not play a major role in perceived breathlessness in patients without airway obstruction, and even less of a role in patients with obstruction. The cumulative dose of agonist did not appear to influence the perception of bronchoconstriction.",
keywords = "Bronchial asthma, Dyspnoea, Hyper-responsiveness",
author = "R. Ottanelli and E. Rosi and I. Romagnoli and Ronchi, {M. C.} and B. Lanini and M. Grazzini and M. Filippelli and L. Stendardi and R. Duranti and Giorgio Scano",
year = "2000",
language = "English",
volume = "98",
pages = "681--687",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "6",

}

TY - JOUR

T1 - Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma

AU - Ottanelli, R.

AU - Rosi, E.

AU - Romagnoli, I.

AU - Ronchi, M. C.

AU - Lanini, B.

AU - Grazzini, M.

AU - Filippelli, M.

AU - Stendardi, L.

AU - Duranti, R.

AU - Scano, Giorgio

PY - 2000

Y1 - 2000

N2 - The inter-relationship between the perception of bronchoconstriction, bronchial hyper-responsiveness and temporal adaptation in asthma is still a matter of debate. In a total of 52 stable asthmatic patients, 32 without airway obstruction [forced expiratory volume in 1 s (FEV 1)/vital capacity (VC) 84.1% (S.D. 7.9%)], and 20 with airway obstruction [FEV 1/VC 60% (4%)], we assessed the perception of bronchoconstriction during methacholine inhalation by using: (i) the slope and intercept of the Borg and VAS (Visual Analog Scale) scores against the decrease in FEV 1, expressed as a percentage of the predicted value; and (ii) the Borg and VAS scores at a 20% decrease in FEV 1 from the lowest post-saline level (PB 20). Bronchial hyper-responsiveness was assessed as the provocative concentration of methacholine causing a 20% fall in FEV 1 (PC 20FEV 1). The reduction in FEV 1 was significantly related to the Borg and VAS scores, with values for the group mean slope and intercept of this relationship of 0.13 (S.D. 0.08) and -1.1 (3.02) for Borg, and 1.5 (1.19) and -12.01 (35) for VAS. PB 20 was 3 (1.75) with Borg scores and 34.6 (20.5) with VAS scores. Compared with the subgroup without airway obstruction, the obstructed subgroup exhibited similar slopes, but lower Borg and VAS intercepts. For similar decreases in FEV 1 (5-20% decreases from the lowest post-saline values), the Borg and VAS scores were lower in the non-obstructed than in the obstructed subgroup. PC 20FEV 1 was significantly related to both Borg PB 20 and VAS PB 20 when considering all patients. When assessing the subgroups, PC 20FEV 1 was related to Borg PB 20 and VAS PB 20 in the non-obstructed subjects, but not in the obstructed subjects. In neither subgroup was the log of the cumulative dose related to the Borg and VAS scores at the end of the test. We conclude that, unlike in previous studies, the ability to perceive acute bronchoconstriction may be reduced as background airflow obstruction increases in asthma. Bronchial hyper-responsiveness did not play a major role in perceived breathlessness in patients without airway obstruction, and even less of a role in patients with obstruction. The cumulative dose of agonist did not appear to influence the perception of bronchoconstriction.

AB - The inter-relationship between the perception of bronchoconstriction, bronchial hyper-responsiveness and temporal adaptation in asthma is still a matter of debate. In a total of 52 stable asthmatic patients, 32 without airway obstruction [forced expiratory volume in 1 s (FEV 1)/vital capacity (VC) 84.1% (S.D. 7.9%)], and 20 with airway obstruction [FEV 1/VC 60% (4%)], we assessed the perception of bronchoconstriction during methacholine inhalation by using: (i) the slope and intercept of the Borg and VAS (Visual Analog Scale) scores against the decrease in FEV 1, expressed as a percentage of the predicted value; and (ii) the Borg and VAS scores at a 20% decrease in FEV 1 from the lowest post-saline level (PB 20). Bronchial hyper-responsiveness was assessed as the provocative concentration of methacholine causing a 20% fall in FEV 1 (PC 20FEV 1). The reduction in FEV 1 was significantly related to the Borg and VAS scores, with values for the group mean slope and intercept of this relationship of 0.13 (S.D. 0.08) and -1.1 (3.02) for Borg, and 1.5 (1.19) and -12.01 (35) for VAS. PB 20 was 3 (1.75) with Borg scores and 34.6 (20.5) with VAS scores. Compared with the subgroup without airway obstruction, the obstructed subgroup exhibited similar slopes, but lower Borg and VAS intercepts. For similar decreases in FEV 1 (5-20% decreases from the lowest post-saline values), the Borg and VAS scores were lower in the non-obstructed than in the obstructed subgroup. PC 20FEV 1 was significantly related to both Borg PB 20 and VAS PB 20 when considering all patients. When assessing the subgroups, PC 20FEV 1 was related to Borg PB 20 and VAS PB 20 in the non-obstructed subjects, but not in the obstructed subjects. In neither subgroup was the log of the cumulative dose related to the Borg and VAS scores at the end of the test. We conclude that, unlike in previous studies, the ability to perceive acute bronchoconstriction may be reduced as background airflow obstruction increases in asthma. Bronchial hyper-responsiveness did not play a major role in perceived breathlessness in patients without airway obstruction, and even less of a role in patients with obstruction. The cumulative dose of agonist did not appear to influence the perception of bronchoconstriction.

KW - Bronchial asthma

KW - Dyspnoea

KW - Hyper-responsiveness

UR - http://www.scopus.com/inward/record.url?scp=0034080361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034080361&partnerID=8YFLogxK

M3 - Article

C2 - 10814605

AN - SCOPUS:0034080361

VL - 98

SP - 681

EP - 687

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 6

ER -